Financial Gravity Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25K Hold
20
﹤0.01% 743
2025
Q4
$1.91K Hold
20
﹤0.01% 606
2025
Q3
$1.95K Buy
+20
New +$2.07K ﹤0.01% 774
2025
Q1
$2.02K Buy
+20
New +$2.01K ﹤0.01% 814
2024
Q2
Sell
-6
Closed -$388 1576
2024
Q1
$388 Buy
6
+5
+500% +$321 ﹤0.01% 1439
2023
Q4
$36 Hold
1
﹤0.01% 1371
2023
Q3
$36 Sell
1
-53
-98% -$2.78K ﹤0.01% 1069
2023
Q2
$985 Buy
54
+4
+8% +$209 ﹤0.01% 817
2023
Q1
$2.32K Buy
+50
New +$2.36K 0.07% 273
2019
Q3
Sell
-233
Closed -$10K 1208
2019
Q2
$10K Buy
+233
New +$8.96K 0.01% 591
2018
Q3
$47K Buy
+1,317
New +$46K 0.05% 339

Other funds holding BSX

Financial Gravity Asset Management's BSX Position: Q1 2026 in Review

Financial Gravity Asset Management held its Boston Scientific (BSX) position steady in Q1 2026 at 20 shares worth $1.25K. The position accounts for ﹤0.01% of the portfolio, ranked #743.

Financial Gravity Asset Management first reported a position in BSX in Q3 2018 and has held it in 11 quarters since. The position peaked at $47K in Q3 2018. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Financial Gravity Asset Management held 20 shares of Boston Scientific worth $1.25K as of Q1 2026.
  • Financial Gravity Asset Management left its Boston Scientific share count unchanged in Q1 2026.
  • Boston Scientific made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #743 holding.
  • Financial Gravity Asset Management first reported a position in Boston Scientific in Q3 2018 and has held it in 11 quarters since.
  • Financial Gravity Asset Management's Boston Scientific position peaked at $47K in Q3 2018.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.